Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Testing revenue106.97M93.48%
Product revenue3.91M3.41%
Biopharmaceutical and other revenue3.55M3.10%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States334.53M92.65%
International26.53M7.35%
